Skip to main content
SpringerLink
Log in

Das lokal fortgeschrittene Prostatakarzinom im Operationspräparat — was tun?

  • Kontroversen in der Uro-Onkologie
  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Anscher MS, Robertson CN, Prosnitz LR (1995) Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten year update. Int J Radiat Oncol Biol Phys 33: 37–43

    Article  CAS  PubMed  Google Scholar 

  2. Catalona WJ, Smith DS (1994) 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. j Urol 152: 1837–1842

    CAS  PubMed  Google Scholar 

  3. Cheng WS, Frydenberg M, Bergstralh MS, Larson-Keller JJ, Zincke H (1993) Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology 42: 283–291

    Article  CAS  PubMed  Google Scholar 

  4. Coetzee LJ, Hars V, Paulson DF (1996) Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. Urology 47: 232–235

    Article  CAS  PubMed  Google Scholar 

  5. Epstein JI, Carmichael MJ, Pizov G, Walsh PC (1993) Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 150: 135–141

    CAS  PubMed  Google Scholar 

  6. Epstein JI, Partin AW, Sauvageot J, Walsh PC (1996) Prediction of progression following radical prostatectomy. Am J Surg Path 20: 286–292

    Article  CAS  PubMed  Google Scholar 

  7. Frazier HA, Robertson JE, Humphrey PA, Paulson DF (1993) Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy. J Urol 149: 516–518

    CAS  PubMed  Google Scholar 

  8. Hanks GE, Asbell S, Krall JM, Perez CA, Doggert S, Rubin P, Sause W, Pilepich MV (1991) Outcome for lymph node dissection negative T1b, T2 (A 2, B) prostate cancer treated with external beam radiation therapy in RTOG 77-06. Int J Radiat Oncol Biol Phys 21: 1099–1103

    Article  CAS  PubMed  Google Scholar 

  9. Kaplan ID, Bagshaw MA (1992) Serum prostatespecific antigen after postprostatectomy radiotherapy. Urology 39: 401–406

    Article  CAS  PubMed  Google Scholar 

  10. Link P, Freiha FS, Stamey TA (1991) Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 145: 532–534

    CAS  PubMed  Google Scholar 

  11. Meier R, Mark R, Royal LS, Tran L, Colburn G, Parker R (1992) Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer 70: 1960–1966

    Article  CAS  PubMed  Google Scholar 

  12. Mukamel E, deKernion JB, Hannah T (1987) The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer 59: 1535–1538

    Article  CAS  PubMed  Google Scholar 

  13. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM (1993) The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Path 17: 1252–1261

    Article  CAS  PubMed  Google Scholar 

  14. Ohori M, Wheeler TM, Dunn JK, Stamey TA, Scardino PT (1994) The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 152: 1714–1720

    CAS  PubMed  Google Scholar 

  15. Partin AW, Borland RN, Epstein JI, Brendler CB (1993) Influence of wide excision of the neurovascular bundle(s) on the prognosis in men with clinically localized prostate cancer with established capsular penetration. J Urol 150: 142–146

    CAS  PubMed  Google Scholar 

  16. Perez CA, Eisbruch A (1993) Role of postradical prostatectomy irradiation in carcinoma of the prostate. Semin Radiooncol 3: 198–209

    Google Scholar 

  17. Pilepich MV, Sause WT, Shipley WU, Krall JM, Lawton CA,Grignon D, Al-Sarraf M, Abrams RA,Caplan R, John MJ, Rotman M, Cox JD, Doggert RLS, Rubin P (1995) Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45: 616–622

    Article  CAS  PubMed  Google Scholar 

  18. Schild SE, Buskirk SJ, Robinow JS, Tomera KM, Ferrigni RG, Frick LM (1992) The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int J Radiat Oncol Biol Phys 23: 141–145

    Article  CAS  PubMed  Google Scholar 

  19. Shevlin BE, Mittal BB, Brand WN, Shetty RM (1989) The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor. Int J Radiat Oncol Biol Phys 16: 1425–1430

    Article  CAS  PubMed  Google Scholar 

  20. Trapasso JG, deKernion JB, Smith RB, Dorey F (1994) The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 152: 1821–1825

    CAS  PubMed  Google Scholar 

  21. Walsh PC, Partin AW, Epstein JI (1994) Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152: 1831–1836

    CAS  PubMed  Google Scholar 

  22. Wiegel T, Bressel M, Carl UM (1995) Adjuvant radiotherapy following radical prostatectomy —results of 56 patients. Eur J Can 31 A: 5–11

    Article  CAS  Google Scholar 

  23. Wu JJ, King SC, Montana GS, McKinstry CA, Anscher MS (1995) The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 32: 317–323

    Article  CAS  PubMed  Google Scholar 

  24. Zietman AL, Edelstein RA, Coen JJ, Babayan RK, Kane RJ (1994) Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology 43: 828–833

    Article  CAS  PubMed  Google Scholar 

  25. Zincke H, Utz DC, Taylor WF (1986) Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. J Urol 135: 1199–1205

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik, Universitätsklinikum Benjamin Franklin, FU Berlin, Hindenburgdamm 30, D-12203, Berlin

    U. Steiner &  K. Miller

Authors
  1. U. Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Steiner, U., Miller, K. Das lokal fortgeschrittene Prostatakarzinom im Operationspräparat — was tun?. Der Urologe B 38, S31–S34 (1998). https://doi.org/10.1007/s001310050370

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050370

Search

Navigation